To date, activity of CD38 antibodies as monotherapy or as adjuvant to donor lymphocyte infusion has been explored in AML (NCT03067571, NCT03537599) (46), though final results have not yet been published. The gene discussed is CD38; the disease is acute myeloid leukemia.